Scilex Holding (SCLX) shares rose 4.3% in recent Wednesday trading after Denali Capital Acquisition (DECA) filed a registration statement on Form S-4 related to the proposed business combination between Denali and Scilex's Semnur Pharmaceuticals unit.
The previously announced merger provides for a pre-transaction equity value of Semnur of $2.5 billion and is anticipated to close in Q1 next year, Semnur said.
Price: 1.10, Change: +0.04, Percent Change: +4.29
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.